Magnetorheology of alginate ferrogels

Magnetorheological (MR) effect is a phenomenon typical of suspensions of magnetizable particles in a liquid carrier, characterized by strong changes of their mechanical properties in response to applied magnetic fields. Its origin is on the migration of magnetized particles and their aggregation into chain-like structures. However, for ferrogels, consisting of dispersions of magnetic particles in a polymer matrix, migration of particles is hindered by the elastic forces of the polymer network, preventing from strong MR effect. Interestingly, we demonstrate in this manuscript that strong MR effect in robustly cross-linked polymer ferrogels is still possible. Experimental results showed enhancement of the storage modulus of more than one order of magnitude for alginate ferrogels containing less than about 10 vol.% of iron particles under moderate magnetic fields. The differential feature of these ferrogels is that, instead of individual particles, the disperse phase consisted of large clusters of iron microparticles homogeneously distributed within the polymer networks. These clusters of magnetic particles were formed at the stage of the preparation of the ferrogels and their presence within the polymer networks had two main consequences. First, the volume fraction of clusters was considerably larger than this of individual particles, resulting in a larger effective volume fraction of solids. Second, since the force of magnetic attraction between magnetic bodies is roughly proportional to the cube of the body size, the existence of such clusters favored inter-cluster interaction under a magnetic field and the appearance of strong MR effect. On this basis, we demonstrated by theoretical modeling that the strong MR effect displayed by the alginate ferrogels of the present work can be quantitatively explained by assuming the existence of large, roughly spherical particle aggregates formed at the stage of the preparation of the ferrogels. Our theoretical model provides a reasonable quantitative prediction of the experimental resultsThis study was supported by project FIS2017-85954-R (Ministerio de Economía, Industria y Competitividad, MINECO, and Agencia Estatal de Investigación, AEI, Spain, cofunded by Fondo Europeo de Desarrollo Regional, FEDER, European Union). CGV acknowledges financial support by Ministerio de Ciencia, Innovación y Universidades and University of Granada, Spain, for her FPU17/00491 grant. AZ is grateful to the Program of the Ministry of Education and Science of the Russian Federation, projects 02.A03.21.0006, 3.1438.2017/4.6, and 3.5214.2017/6.7 and the Russian Fund of Basic Researches, project 18-08-0017

Microclimate monitoring of Ariadne's house (Pompeii, Italy) for preventive conservation of fresco paintings

Background: Ariadne's house, located at the city center of ancient Pompeii, is of great archaeological value due to the fresco paintings decorating several rooms. In order to assess the risks for long-term conservation affecting the valuable mural paintings, 26 temperature data-loggers and 26 relative humidity data-loggers were located in four rooms of the house for the monitoring of ambient conditions. Results: Data recorded during 372 days were analyzed by means of graphical descriptive methods and analysis of variance (ANOVA). Results revealed an effect of the roof type and number of walls of the room. Excessive temperatures were observed during the summer in rooms covered with transparent roofs, and corrective actions were taken. Moreover, higher humidity values were recorded by sensors on the floor level. Conclusions: The present work provides guidelines about the type, number, calibration and position of thermohygrometric sensors recommended for the microclimate monitoring of mural paintings in outdoor or semi-confined environments. © 2012 Merello et al.; licensee Chemistry Central Ltd.This work was partially supported by the Spanish Government (Ministerio de Ciencia e Innovacion) under projects HAR2010-21944-C02-01 and HAR2010-21944-C02-02.Merello Giménez, P.; García Diego, FJ.; Zarzo Castelló, M. (2012). Microclimate monitoring of Ariadne's house (Pompeii, Italy) for preventive conservation of fresco paintings. Chemistry Central Journal. 6:145-161. https://doi.org/10.1186/1752-153X-6-145S1451616Ribera A, Olcina M, Ballester C: Pompeya Bajo Pompeya, las Excavaciones en la Casa de Ariadna. Valencia: Fundación MARQ; 2007.World Monuments Fund: World Monuments Watch: 100 Most Endangered Sites. New York: World Monuments Fund; 1996.Anter KF: Colours in Pompeiian cityscape: Adding pieces to the puzzle. Color Res Appl 2006,31(4):331–340.Harris J: Protecting Pompeii and the Italian heritage in 2012. http://www.i-italy.org/bloggers/18935/protecting-pompeii-and-italian-heritage-2012Augusti S: La Tecnica Dell’antica Pittura Parietale Pompeiana. Napoli: Gaetano Macchiaroli Editore; 1950.Miriello D, Barca D, Bloise A, Ciarallo A, Crisci GM, De Rose T, Gattuso C, Gazineo F, La Russa MF: Characterisation of archaeological mortars from Pompeii (Campania, Italy) and identification of construction phases by compositional data analysis. J Arch Sci 2010, 37:2207–2223.Castriota M, Cosco V, Barone T, De Santo G, Carafa P, Cazzanelli E: Micro-Raman characterizations of Pompei’s mortars. J Raman Spectrosc 2008,39(2):295–301.Maguregui M, Knuutinen U, Castro K, Madariaga JM: Raman spectroscopy as a tool to diagnose the impact and conservation state of Pompeian second and fourth style wall paintings exposed to diverse environments (House of Marcus Lucretius). J Raman Spectrosc 2010,41(11):1400–1409.Genestar C, Pons C, Más A: Analytical characterisation of ancient mortars from the archaeological Roman city of Pollentia (Balearic Islands, Spain). Anal Chim Acta 2006, 557:373–379.Duran A, Perez-Maqueda LA, Poyato J, Perez-Rodriguez JL: A thermal study approach to roman age wall painting mortars. J Therm Anal Calorim 2010,99(3):803–809.Pérez MC, García Diego F-J, Merello P, D’Antoni P, Fernández Navajas A, Ribera Lacomba A, Ferrazza L, Pérez Miralles J, Baró JL, Merce P, D’Antoni H, Curiel Esparza J: Ariadne’s house (Pompeii, Italy) wall paintings: a multidisciplinary study of its present state focused on a future restoration and preventive conservation. Mater Constr in pressBernardi A: Microclimate in the British Museum. London. Museum Manag Curat 1990, 9:169–182.Bernardi A, Camuffo D: Microclimate in the Chiericati Palace Municipal Museum. Vicenza. Museum Manag Curat 1995, 14:5–18.Camuffo D, Bernardi A, Sturaro G, Valentino A: The microclimate inside the Pollaiolo and Botticelli rooms in the Uffizi Gallery. Florence. J Cult Herit 2002, 3:155–161.La Gennusa M, Rizzo G, Scaccianoce G, Nicoletti F: Control of indoor environments in heritage buildings: Experimental measurements in an old Italian museum and proposal of a methodology. J Cult Herit 2005,6(2):147–155.Camuffo D, Sturaro G, Valentino A: Thermodynamic exchanges between the external boundary layer and the indoor microclimate at the Basilica of Santa Maria Maggiore, Rome, Italy: the problem of conservation of ancient works of art. Bound Lay Meteorol 1999, 92:243–262.Tabunschikov Y, Brodatch M: Indoor air climate requirements for Russian churches and cathedrals. Indoor Air 2004,14(Suppl 7):168–174.Loupa G, Charpantidou E, Kioutsioukis I, Rapsomanikis S: Indoor microclimate, ozone and nitrogen oxides in two medieval churches in Cyprus. Atmos Environ 2006, 40:7457–7466.Vuerich E, Malaspina F, Barazutti M, Georgiadis T, Nardino M: Indoor measurements of microclimate variables and ozone in the church of San Vincenzo (Monastery of Bassano Romano – Italy): a pilot study. Microchem J 2008, 88:218–223.García-Diego F-J, Zarzo M: Microclimate monitoring by multivariate statistical control: the renaissance frescoes of the cathedral of valencia (Spain). J Cult Herit 2010,11(3):339–344.Zarzo M, Fernández-Navajas A, García-Diego F-J: Long-term monitoring of fresco paintings in the Cathedral of Valencia (Spain) through humidity and temperature sensors in various locations for preventive conservation. Sensors 2011,11(9):8685–8710.Maekawa S, Lambert F, Meyer J: Environmental monitoring at Tiwanaku. Mater Res Soc Symp Proc 1995, 352:885–892.Lillie M, Smith R, Reed J, Inglis R: Southwest Scottish Crannogs: using in situ studies to assess preservation in wetland archaeological contexts. J Archaeol Sci 2008,35(7):1886–1900.Verdecchia F, Zoccatelli C, Norelli E, Miandro R: Integrated monitoring network for surface deformation in Capo Colonna archaeological area, Crotone. Italy. IAHS-AISH P 2010, 339:345–351.Nava S, Becherini F, Bernardi A, Bonazza A, Chiari M, García-Orellana I, Lucarelli F, Ludwig N, Migliori A, Sabbioni C, Udisti R, Valli G, Vecchi R: An integrated approach to assess air pollution threats to cultural heritage in a semi-confined environment: the case study of Michelozzo’s Courtyard in Florence (Italy). Sci Total Environ 2010,408(6):1403–1413.Hygrochron Temperature/Humidity Logger iButton with 8KB Data-Log Memory. Maxim Integrated Products. http://datasheets.maxim-ic.com/en/ds/DS1923.pdfTemperature Logger iButton with 8KB Data-Log Memory. Maxim Integrated Products. http://datasheets.maxim-ic.com/en/ds/DS1922L-DS1922T.pdfVisco G, Plattner SH, Fortini P, Di Giovanni S, Sammartino MP: Microclimate monitoring in the Carcer Tullianum: temporal and spatial correlation and gradients evidenced by multivariate analysis; first campaign. Chem Cent J 2012,6(Suppl 2):S11.UNI 10829: Works of Art of Historical Importance. Ambient Conditions for the Conservation. Measurement and Analysis. Milano: UNI Ente Nazionale Italiano di Unificazione; 1999.DM 10/2001: Atto di Indirizzo sui Criteri Tecnico-scientifici e Sugli Standard di Funzionamento e Sviluppo dei Musei. Ministero per i Beni e le Attività Culturali. Gazzeta Ufficiale della Repubblica Italiana (Official Bulletin of Italian Republica), Rome (Italy); 2001. DL 112/1998 art. 150 comma 6Camuffo D: Microclimate for Cultural Heritage. Amsterdam: Elsevier Science; 1998.ASTM E 104–02: Standard Practice for Maintaining Constant Relative Humidity by Means of Aqueous Solutions. West Conshohocken, PA: ASTM Intl; 2012.Statgraphics Software. http://www.statgraphics.ne

Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis

Working memory capacity, a critical component of executive function, expands developmentally from childhood through adulthood. Anomalies in this developmental process are seen in individuals with autism spectrum disorder (ASD), schizophrenia and intellectual disabilities (ID), implicating this atypical process in the trajectory of developmental neuropsychiatric disorders. However, the cellular and neuronal substrates underlying this process are not understood. Duplication and triplication of copy number variants of 22q11.2 are consistently and robustly associated with cognitive deficits of ASD and ID in humans, and overexpression of small 22q11.2 segments recapitulates dimensional aspects of developmental neuropsychiatric disorders in mice. We capitalized on these two lines of evidence to delve into the cellular substrates for this atypical development of working memory. Using a region- and cell-type-selective gene expression approach, we demonstrated that copy number elevations of catechol-O-methyl-transferase (COMT) or Tbx1, two genes encoded in the two small 22q11.2 segments, in adult neural stem/progenitor cells in the hippocampus prevents the developmental maturation of working memory capacity in mice. Moreover, copy number elevations of COMT or Tbx1 reduced the proliferation of adult neural stem/progenitor cells in a cell-autonomous manner in vitro and migration of their progenies in the hippocampus granular layer in vivo. Our data provide evidence for the novel hypothesis that copy number elevations of these 22q11.2 genes alter the developmental trajectory of working memory capacity via suboptimal adult neurogenesis in the hippocampus.Peer reviewe

Impact of the Mitochondrial Genetic Background in Complex III Deficiency

BACKGROUND: In recent years clinical evidence has emphasized the importance of the mtDNA genetic background that hosts a primary pathogenic mutation in the clinical expression of mitochondrial disorders, but little experimental confirmation has been provided. We have analyzed the pathogenic role of a novel homoplasmic mutation (m.15533 A>G) in the cytochrome b (MT-CYB) gene in a patient presenting with lactic acidosis, seizures, mild mental delay, and behaviour abnormalities. METHODOLOGY: Spectrophotometric analyses of the respiratory chain enzyme activities were performed in different tissues, the whole muscle mitochondrial DNA of the patient was sequenced, and the novel mutation was confirmed by PCR-RFLP. Transmitochondrial cybrids were constructed to confirm the pathogenicity of the mutation, and assembly/stability studies were carried out in fibroblasts and cybrids by means of mitochondrial translation inhibition in combination with blue native gel electrophoresis. PRINCIPAL FINDINGS: Biochemical analyses revealed a decrease in respiratory chain complex III activity in patient's skeletal muscle, and a combined enzyme defect of complexes III and IV in fibroblasts. Mutant transmitochondrial cybrids restored normal enzyme activities and steady-state protein levels, the mutation was mildly conserved along evolution, and the proband's mother and maternal aunt, both clinically unaffected, also harboured the homoplasmic mutation. These data suggested a nuclear genetic origin of the disease. However, by forcing the de novo functioning of the OXPHOS system, a severe delay in the biogenesis of the respiratory chain complexes was observed in the mutants, which demonstrated a direct functional effect of the mitochondrial genetic background. CONCLUSIONS: Our results point to possible pitfalls in the detection of pathogenic mitochondrial mutations, and highlight the role of the genetic mtDNA background in the development of mitochondrial disorders

Measurement of the W-Pair Production Cross Section and W-Decay Branching Fractions in e+e−e^{+}e^{-} Interactions at s\sqrt{s}= 189 GeV

The data collected by the L3 experiment at LEP at a centre-of-mass energy of $188.6~\rm{Ge\kern -0.1em V}$ are used to measure the W-pair production cross section and the W-boson decay branching fractions. These data correspond to an integrated luminosity of 176.8~pb$^{-1}$. The total cross section for W-pair production, combining all final states, is measured to be $\sigma_{\rm{WW}}= 16.24 \pm 0.37~(stat.) \pm 0.22~(syst.)$~pb. Including our data collected at lower centre-of-mass energies, the hadronic branching fraction of the W-boson is determined to be $B(\rm{W} \rightarrow \rm{qq})= \left[ 68.20 \pm 0.68~(stat.) \pm 0.33~(syst.)\right]~\%$. The results agree with the Standard Model predictions.The data collected by the L3 experiment at LEP at a centre-of-mass energy of 188.6 GeV are used to measure the W-pair production cross section and the W-boson decay branching fractions. These data correspond to an integrated luminosity of 176.8pb^-1. The total cross section for W-pair production, combining all final states, is measured to be sigma_WW = 16.24 +/- 0.37(stat.) +/- 0.22(syst.) pb. Including our data collected at lower centre-of-mass energies, the hadronic branching fraction of the W-boson is determined to be B(W ->qq) = [68.20 +/- 0.68 (stat.) +/- 0.33 (syst.) ] %. The results agree with the Standard Model predictions.The data collected by the L3 experiment at LEP at a centre-of-mass energy of 188.6 GeV are used to measure the W-pair production cross section and the W-boson decay branching fractions. These data correspond to an integrated luminosity of 176.8 pb −1 . The total cross section for W-pair production, combining all final states, is measured to be σ WW =16.24±0.37 (stat.)±0.22 (syst.) pb. Including our data collected at lower centre-of-mass energies, the hadronic branching fraction of the W-boson is determined to be B (W→qq)=[68.20±0.68 (stat.)±0.33 (syst.)]%. The results agree with the Standard Model predictions

Combinations of single-top-quark production cross-section measurements and vertical bar f(LV)V(tb)vertical bar determinations at root s=7 and 8 TeV with the ATLAS and CMS experiments

This paper presents the combinations of single-top-quark production cross-section measurements by the ATLAS and CMS Collaborations, using data from LHC proton-proton collisions at = 7 and 8 TeV corresponding to integrated luminosities of 1.17 to 5.1 fb(-1) at = 7 TeV and 12.2 to 20.3 fb(-1) at = 8 TeV. These combinations are performed per centre-of-mass energy and for each production mode: t-channel, tW, and s-channel. The combined t-channel cross-sections are 67.5 +/- 5.7 pb and 87.7 +/- 5.8 pb at = 7 and 8 TeV respectively. The combined tW cross-sections are 16.3 +/- 4.1 pb and 23.1 +/- 3.6 pb at = 7 and 8 TeV respectively. For the s-channel cross-section, the combination yields 4.9 +/- 1.4 pb at = 8 TeV. The square of the magnitude of the CKM matrix element V-tb multiplied by a form factor f(LV) is determined for each production mode and centre-of-mass energy, using the ratio of the measured cross-section to its theoretical prediction. It is assumed that the top-quark-related CKM matrix elements obey the relation |V-td|, |V-ts| << |V-tb|. All the |f(LV)V(tb)|(2) determinations, extracted from individual ratios at = 7 and 8 TeV, are combined, resulting in |f(LV)V(tb)| = 1.02 +/- 0.04 (meas.) +/- 0.02 (theo.). All combined measurements are consistent with their corresponding Standard Model predictions.Peer reviewe

The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Background: Innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer. However, we still lack high-level evidence in many areas relevant to making management decisions in daily clinical practise. The 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) addressed some questions in these areas to supplement guidelines that mostly are based on level 1 evidence. Objective: To present the voting results of the APCCC 2022. Design, setting, and participants: The experts voted on controversial questions where high- level evidence is mostly lacking: locally advanced prostate cancer; biochemical recurrence after local treatment; metastatic hormone-sensitive, non-metastatic, and metastatic castration- resistant prostate cancer; oligometastatic prostate cancer; and managing side effects of hormonal therapy. A panel of 105 international prostate cancer experts voted on the consensus questions. Outcome measurements and statistical analysis: The panel voted on 198 pre-defined questions, which were developed by 117 voting and non-voting panel members prior to the conference following a modified Delphi process. A total of 116 questions on metastatic and/or castration- resistant prostate cancer are discussed in this manuscript. In 2022, the voting was done by a web-based survey because of COVID-19 restrictions. Results and limitations: The voting reflects the expert opinion of these panellists and did not incorporate a standard literature review or formal meta-analysis. The answer options for the consensus questions received varying degrees of support from panellists, as reflected in this article and the detailed voting results are reported in the supplementary material. We report here on topics in metastatic, hormone-sensitive prostate cancer (mHSPC), non-metastatic, castration-resistant prostate cancer (nmCRPC), metastatic castration-resistant prostate cancer (mCRPC), and oligometastatic and oligoprogressive prostate cancer. Conclusions: These voting results in four specific areas from a panel of experts in advanced prostate cancer can help clinicians and patients navigate controversial areas of management for which high-level evidence is scant or conflicting and can help research funders and policy makers identify information gaps and consider what areas to explore further. However, diagnostic and treatment decisions always have to be individualised based on patient characteristics, including the extent and location of disease, prior treatment(s), co-morbidities, patient preferences, and treatment recommendations and should also incorporate current and emerging clinical evidence and logistic and economic factors. Enrolment in clinical trials is strongly encouraged. Importantly, APCCC 2022 once again identified important gaps where there is non-consensus and that merit evaluation in specifically designed trials. Patient summary: The Advanced Prostate Cancer Consensus Conference (APCCC) provides a forum to discuss and debate current diagnostic and treatment options for patients with advanced prostate cancer. The conference aims to share the knowledge of international experts in prostate cancer with healthcare providers worldwide. At each APCCC, an expert panel votes on pre-defined questions that target the most clinically relevant areas of advanced prostate cancer treatment for which there are gaps in knowledge. The results of the voting provide a practical guide to help clinicians discuss therapeutic options with patients and their relatives as part of shared and multidisciplinary decision-making. This report focuses on the advanced setting, covering metastatic hormone-sensitive prostate cancer and both non-metastatic and metastatic castration-resistant prostate cancer. Twitter summary: Report of the results of APCCC 2022 for the following topics: mHSPC, nmCRPC, mCRPC, and oligometastatic prostate cancer. Take-home message: At APCCC 2022, clinically important questions in the management of advanced prostate cancer management were identified and discussed, and experts voted on pre-defined consensus questions. The report of the results for metastatic and/or castration- resistant prostate cancer is summarised here